A preface to the newsletter: This was a shortened trading week due to the Good Friday holiday, but that didn't deter the volatility, with stocks and oil prices swinging both directions. Geopolitical chaos is driving the markets and will continue to do so until we see some light at the end of the tunnel of this conflict. Stay disciplined, don't let headlines drive you mad, and invest with an eye to the long term rather than the day-to-day.
Additionally, I believe that planning for a long life means more than managing the financial side of it. It means thinking seriously about the quality of that life: the health, vitality, and freedom that make wealth meaningful in the first place. That's why I'm proud to partner with the Longevity Science Foundation (LSF) to bring longevity science and long-term health planning into this newsletter alongside financial planning. Over the coming issues, the LSF, led by President & CEO Joshua Herring, will share insights from the frontier of longevity research - science separated from marketing, where philanthropic capital is making a difference, and how you can be part of it. This week and next will feature an introduction to LSF and their mission, and then we will focus on specific health issues. My goal in partnering with LSF is to help share knowledge concerning both personal and financial wellness, so we can all live better. Please let me know if there are any specific health and wellness topics that you would like me to include in future newsletters.
Kevin
The Iran war and the Strait of Hormuz remain the #1 concern.
The conflict, now in its sixth week, has disrupted roughly 20% of the world's oil supply. Gas prices have climbed past $4 per gallon nationally (I recently paid $6.30 per gallon here in Clayton, CA). The IEA, the world's energy watchdog, called this the biggest oil supply disruption in modern history.
Stock markets rallied sharply on Tuesday when ceasefire signals emerged, however oil prices jumped during President Trump’s speech on Wednesday when no clear ending was outlined. The most important thing right now is not to let daily headlines drive decisions. The situation is fluid, and overreacting often causes investors lose money.
The March jobs report came in much better than expected.
The U.S. economy added 178,000 jobs last month, nearly 3x what economists had predicted, and the unemployment rate edged down to 4.3%. Health care and construction jobs were the most plentiful.
A resilient job market is good news. Despite all the chaos, the underlying economy has shown surprising durability. The strong jobs number also likely keeps the Fed policy on hold for now, meaning interest rates will probably stay where they are through the next meeting at the end of April.
Corporate earnings and deal activity provided some positive news and a refreshing distraction from geopolitics.
Today’s war harkens back to David and Goliath. Iran has a seemingly unlimited supply of cheap bombs loaded onto drones and speedboats like rocks to sling, while our defenses are measured in the millions of dollars per shot.
"Near term measures of inflation expectations have risen in recent weeks, likely reflecting the substantial rise in oil prices caused by the supply disruptions in the Middle East." - Fed Chair Jerome Powell
The Fed is walking a tightrope between fighting inflation and supporting the economy during wartime uncertainty. While oil price spikes are concerning, Powell emphasized that these disruptions may be temporary, which is why they're holding rates steady for now. Many economists are now forecasting rising inflation ahead, however the Fed wants to see how the geopolitical situation unfolds before making any major policy changes.
Current CPI, as of February, remains stubbornly at 2.4%. Although this is down significantly from the highs of the past several years, many economists suggest inflation could surprise at levels exceeding 4% by the end of 2026. The Congressional Budget Office has revised projections upward, specifically citing the inflationary impact of new trade policies, and most consensus models indicate inflation will remain significantly above the Fed’s 2% target through 2026.
What can we, as consumers and investors, do in our daily lives to manage rising prices?
A different way to think about agency in long term health & philanthropy.
The Longevity Science Foundation is a US-based 501(c)(3) nonprofit founded in 2022 by a team of successful biotech venture capitalists. Having spent careers at the intersection of science, tech, and investment, the founding team identified the single biggest gap in driving meaningful health outcomes: research - early-stage, prevention-focused science that could change the trajectory of how we age before disease ever takes hold.
The LSF was built to close a critical gap in research funding and acceleration. It uses a global network and infrastructure to source, diligence, fund, and accelerate underfunded research across three verticals:
Age-related disease
The LSF guides philanthropic capital, with a deliberate focus on academic research settings - where the majority of innovation happens, yet traditional funding is scarcest. Current and prospective work include cardiometabolic health research at the University of Oxford, novel neurodegenerative disease prevention at the University of Copenhagen, and projects spanning Harvard, Yale, Massachusetts General Hospital, Imperial College London, and many more.
The foundation deploys 100% of donations directly to research. Its founding team covers all operational costs, so no philanthropic dollar is absorbed by overhead.
The Problem Worth Solving
As a society, we've been conditioned to treat Alzheimer's, cancer, and cardiovascular disease as the natural costs of living a long life. The LSF operates from a different premise: these are not inevitabilities. They are, in many cases, conditions that early prediction and prevention science can meaningfully intercept — if given the resources to do so.
The Trusted Voice in a Noisy Space
The longevity industry has a credibility problem. Products, protocols, and claims proliferate faster than the science behind them. The LSF's role in education, as a nonprofit with no commercial stake in outcomes, is to serve as a truth broker: analyzing ideas from a rigorous scientific framework, separating evidence from marketing, and making that accessible to anyone who wants real answers.
The goal isn't to sell longevity. It's to make the science clear enough that the noise becomes obvious.
To learn more, go to: https://longevity.foundation/
Have a nice week ahead!
Kevin